Company profile for Adocia

NEW Drugs in Dev.: 11
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Innovative medicine for everyone, everywhere"​ Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safet...
Innovative medicine for everyone, everywhere"​ Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
115 avenue Lacassagne, LYON, 69003
Telephone
Telephone
33 (0)4 72 610 610
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-01-09/number-of-shares-and-voting-rights-of-adocia-as-of-december-31st-2025

PHARMIWEB
09 Jan 2026

https://www.pharmiweb.com/press-release/2025-12-18/adocia-announces-its-financial-calendar-for-2026

PHARMIWEB
18 Dec 2025

https://www.pharmiweb.com/press-release/2025-12-08/number-of-shares-and-voting-rights-of-adocia-as-of-december-8th-2025

PHARMIWEB
08 Dec 2025

https://www.pharmiweb.com/press-release/2025-10-15/adocia-and-tonghua-dongbao-announce-positive-topline-results-of-phase-3-clinical-trial-on-ultra-rapi

PHARMIWEB
15 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-15/adocia-reports-third-quarter-2025-financial-results-and-provides-a-business-update

PHARMIWEB
15 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-10/number-of-shares-and-voting-rights-of-adocia-as-of-september-30th-2025

PHARMIWEB
10 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty